Hyubika Tablets 5/20 mg

Adult dose

This medication is taken once daily, 1 tablet, with or without food. It is recommended that it be taken at the same time every day (e.g., in the morning). The recommended dosing regimen is as follows: - 5/20 mg: For patients whose blood pressure is not adequately controlled with Amlodipine 5 mg or Olmesartan Medoxomil 20 mg monotherapy. - 10/20 mg: For patients whose blood pressure is not adequately controlled with Olmesartan Medoxomil 20 mg.

Child dose

The safety and efficacy of this medication in pediatric patients under 18 years of age have not been established.

This medication may cause serious harm to the fetus and newborn when taken during the 2nd and 3rd trimesters of pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. Patients with allergies to the active ingredients or similar classes of medications, those who are pregnant or breastfeeding, individuals with severe liver disease, certain heart conditions, patients on kidney dialysis, those in shock, and patients with particular diabetes conditions should not take this medication. Patients who are fluid or sodium depleted, those sensitive to vasodilator medications, patients with severe heart disease, and those with diminished kidney function should be particularly cautious and observe their condition carefully when taking this medication. Side effects such as dizziness, headache, blood pressure drops, indigestion, swelling, and rashes may occur, and immediate consultation with a physician is required if any unusual symptoms arise. Sudden discontinuation of beta-blockers can be risky, so patients currently taking beta-blockers should gradually reduce their dose under medical guidance. This medication may interact with other antihypertensive medications, diuretics, potassium-sparing medications, lithium, and non-steroidal anti-inflammatory drugs, so patients should inform their doctor or pharmacist of any other drugs they are taking. This medication should not be taken during pregnancy, and patients planning to become pregnant should switch to a safer alternative treatment. Breastfeeding mothers should consider discontinuing breastfeeding or this medication as it may be passed to the infant through breast milk. Safety and efficacy in patients under 18 years of age have not been established; hence, its use is not recommended in this age group. Elderly patients may experience decreased kidney and liver function, necessitating dose adjustments and close monitoring during treatment. In cases of overdose, symptoms such as hypotension, vasodilation, and arrhythmias may occur, requiring immediate medical attention. This medication should be stored out of direct sunlight and moisture in a place inaccessible to children, and it is advisable not to transfer it to another container.

Serious side effects

Hives, severe swelling (edema), skin peeling, pain in oral/conjunctival mucosa, difficulty breathing, chest tightness, severe allergic reactions, severe skin reactions, respiratory distress, asthma attacks, cough accompanied by fever and respiratory anomalies, jaundice (yellowing of skin or eyes), extreme lethargy, liver damage (jaundice), sudden and severe headaches, seizures, confusion, visual disturbances, paralysis, severe neurological symptoms.

Mild side effects

• Dizziness
• headache
• drowsiness
• sensory disturbances
• sensory loss
• syncope
• vertigo
• palpitations
• rapid heartbeat
• hypotension

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. Additionally, it is best stored at room temperature between 1°C and 30°C to maintain its potency for an extended period.

Appearance

White round film-coated tablet

Package unit

30 tablets/PTP [10 tablets/PTP x 3]